GC
USPH icon

Guggenheim Capital’s US Physical Therapy USPH Stock Holding History

Guggenheim Capital’s Portfolio USPH Stock Details USPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,983
Closed -$797K – 2810
2017
Q3 		$797K Buy
12,983
+1,213
+10% +$73.9K ﹤0.01% 2202
2017
Q2 		$710K Sell
11,770
-409
-3% -$26.1K ﹤0.01% 2266
2017
Q1 		$794K Sell
12,179
-1,392
-10% -$98.7K ﹤0.01% 2223
2016
Q4 		$953K Sell
13,571
-8,105
-37% -$516K ﹤0.01% 2165
2016
Q3 		$1.36M Sell
21,676
-2,819
-12% -$174K ﹤0.01% 1885
2016
Q2 		$1.48M Sell
24,495
-1,327
-5% -$72.7K ﹤0.01% 1769
2016
Q1 		$1.28M Sell
25,822
-7,332
-22% -$364K ﹤0.01% 1885
2015
Q4 		$1.78M Buy
+33,154
New +$1.66M 0.01% 1699
2014
Q3 		– Sell
-6,288
Closed -$215K – 3119
2014
Q2 		$215K Sell
6,288
-627
-9% -$20.2K ﹤0.01% 2881
2014
Q1 		$239K Buy
6,915
+1,146
+20% +$38K ﹤0.01% 2823
2013
Q4 		$203K Buy
+5,769
New +$189K ﹤0.01% 2839

Other funds holding USPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Guggenheim Capital's USPH Position: Q4 2017 in Review

Guggenheim Capital sold out of US Physical Therapy (USPH) in Q4 2017, closing a stake of 12,983 shares — an estimated $797K sold.

Guggenheim Capital first reported a position in USPH in Q4 2013 and held it in 11 quarters. The position peaked at $1.78M in Q4 2015. 167 funds tracked by Wall St. Rank hold USPH as of Q4 2017.

  • Guggenheim Capital reported no remaining US Physical Therapy position as of Q4 2017 after selling out during the quarter.
  • Guggenheim Capital sold 12,983 US Physical Therapy shares in Q4 2017, an estimated $797K.
  • Guggenheim Capital first reported a position in US Physical Therapy in Q4 2013 and held it in 11 quarters.
  • Guggenheim Capital's US Physical Therapy position peaked at $1.78M in Q4 2015.
  • 167 funds tracked by Wall St. Rank held US Physical Therapy as of Q4 2017.

Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.